The Next Era in Pathway Proteomics: Turnkey Targeted Quantitation Workflows

REGISTER NOW Broadcast Date: October 1, 2019 Time: 8:00 am PT, 11:00 am ET, 17:00 CET Accurate monitoring of cell signaling pathway proteins, particularly tyrosine phosphorylation (pTyr)...

Rethinking Rx-Dx Codevelopment

Codevelopment is an intermittent and uncertain process. Adopting an agnostic approach to the challenges associated with platform and method selection provide added degrees of freedom for strategic development and selection of the most appropriate clinical trial assay.

Liquid Biopsy and ddPCR: A Match with Quality in Mind

In this webinar we will hear how GenQA addresses some of the challenges in providing quality assessments for ctDNA testing.

Immunotherapy and Cancer: Harnessing the Power of Diagnostic Assays

In this eBook learn how MolecularMD is harnessing the company's unique capabilities to address diagnostic needs within immuno-oncology.

Advancing Mass Spectrometry-Based Large-Cohort Proteomics for Precision Medicine

Large cohort studies are essential to the discovery of protein biomarkers, and their validation is indispensable to clinical utility.

How Multi-Omics Profiling Can Redefine Precision Health and Medicine

Coupling relatively routine datasets such as genomes and transcriptomes with newer types produces an “integrative Personal Omics Profile".
isoplexis eBook cover

Single-Cell Functional Proteomics Accelerates Immunotherapy Development Opportunities from Pre-Clinical to Clinical Stages

IsoPlexis’ next generation systems provide actionable potency, safety, and patient difference metrics by detecting highly potent single cell functional subsets for the first time.

Rise of Genomics in Clinical Trials

The challenges of incorporating NGS into clinical trials is being addressed through the adoption of robust technology solutions.

Conquering CML: The Breakthrough Paradigm Change of Treatment-free Remission

Download this eBook to learn how MolecularMD helped usher in a new era of CML treatment now prescribed by progressive clinicians.

Multiplexed Mass Spectrometry Solutions for Cancer Proteomics

In this webinar, multiplexing quantitative proteomics for profiling breast cancer patient-derived xenografts will be discussed.
Scroll Up